- Home
- AQMS vs SILO Comparison
AQMS vs SILO Comparison
Compare AQMS & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- SILO
- Stock Information
- Founded
- AQMS 2014
- SILO 2010
- Country
- AQMS United States
- SILO United States
- Employees
- AQMS N/A
- SILO N/A
- Industry
- AQMS Metal Fabrications
- SILO Apparel
- Sector
- AQMS Industrials
- SILO Consumer Discretionary
- Exchange
- AQMS Nasdaq
- SILO Nasdaq
- Market Cap
- AQMS 5.2M
- SILO 4.5M
- IPO Year
- AQMS 2015
- SILO N/A
- Fundamental
- Price
- AQMS $3.87
- SILO $0.60
- Analyst Decision
- AQMS Strong Buy
- SILO
- Analyst Count
- AQMS 3
- SILO 0
- Target Price
- AQMS $210.00
- SILO N/A
- AVG Volume (30 Days)
- AQMS 113.4K
- SILO 740.3K
- Earning Date
- AQMS 08-13-2025
- SILO 08-12-2025
- Dividend Yield
- AQMS N/A
- SILO N/A
- EPS Growth
- AQMS N/A
- SILO N/A
- EPS
- AQMS N/A
- SILO N/A
- Revenue
- AQMS N/A
- SILO $72,102.00
- Revenue This Year
- AQMS N/A
- SILO $1.86
- Revenue Next Year
- AQMS $550.00
- SILO N/A
- P/E Ratio
- AQMS N/A
- SILO N/A
- Revenue Growth
- AQMS N/A
- SILO N/A
- 52 Week Low
- AQMS $3.40
- SILO $0.41
- 52 Week High
- AQMS $54.00
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- AQMS 31.41
- SILO 43.80
- Support Level
- AQMS $3.40
- SILO $0.65
- Resistance Level
- AQMS $4.53
- SILO $0.78
- Average True Range (ATR)
- AQMS 0.55
- SILO 0.06
- MACD
- AQMS -0.07
- SILO -0.00
- Stochastic Oscillator
- AQMS 4.81
- SILO 4.17
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.